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explain their reported good efﬁcacy in OA treatment. Our results
highlight the synergic effect of the combined administration and
point out the effectiveness of both molecules as anti-inﬂammatory
drugs.
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Purpose: The self-assembling peptide (KLDL)3, or KLD, has been
shown to have chondrogenic properties in vitro. In addition, TGF-
β1 and dexamethasone are crucial for inducing chondrogenesis
of bone marrow-derived stromal cells (BMSCs) in vitro, and IGF-1
promotes biosynthesis of sGAGs by chondrocytes. The goal of
this study was to optimize conditions to provide the best repair in
a rabbit model.
Methods: In Vitro Tissue Engineering: Bone marrow was har-
vested from bovine calves. BMSCs were selected via differential
adhesion and expanded 2 passages in LGDMEM with 10% FBS
& 5ng/mL FGF-2. KLD peptide (0.35% w/v) was pre-mixed with
100ng/mL TGF-β1 and 100nM dexamethasone, with or without
300 ng/mL IGF-1, prior to adding cells. BMSCs were encapsu-
lated in KLD/GF mixture at 10 million/mL. Gels were cultured in 1%
ITS + HGDMEM. sGAG retained in each hydrogel was quantiﬁed
by DMMB dye binding. DNA was quantiﬁed by Hoechst dye assay.
During the ﬁnal 24 h of culture, 5μ Ci/mL 35S-sulfate and 10μ
Ci/mL 3H-proline was added to medium to quantify proteoglycan
(PG) and protein synthesis.
In Vivo Rabbit Model: Three different conditions were tested: KLD
alone, KLD + GF, and KLD + GF + BMSCs. Based on the in vitro
study, 100ng/mL TGF-β1, 100 nM dexamethasone, and 300 ng/mL
IGF-1 were used together as the growth factor (GF) combination
pre-mixed with KLD prior to injection. BMSCs were allogenic. In 32
female 8-month-old New Zealand White rabbits, a 3mm diameter
Abstract 479 – Figure 1. In vitro DNA and ECM Content and Biosynthesis.
Figure 2. Representative Safranin-O staining for in vivo defect repair. KLD only
treated had signiﬁcantly higher staining than the bilateral empty control.
full-thickness defect was created in the femoropatellar groove of
each knee. GF and cells were pre-mixed with KLD and directly
injected into left-knee defects with right-knee defects left empty as
controls. There were 6-7 rabbits used for each condition. ACUC
approval was given by CSU. Repair tissue was analyzed by gross
and histological scoring.
Results: In vitro testing conﬁrmed that including IGF-1, along with
TGF-β1 and dexamethasone, improved chondrogenesis of BM-
SCs in KLD as shown by higher sGAG content and PG synthesis
(Fig. 1). However, in the rabbit model, the KLD group without any
growth factors or cells showed the greatest repair after 12 weeks.
KLD had a signiﬁcantly higher total histology score and more
Safranin-O staining (Fig. 2, 3). Including BMSCs with GF resulted
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Abstract 479 – Figure 3. Histology Scores for in vivo defect repair. *vs. untreated KLD, M (treated + untreated) vs. KLD + GF + MSCs (treated + untreated), U (treated)
vs. (untreated).
in signiﬁcantly lower surface regularity scores compared to KLD or
KLD+GFs and signiﬁcantly more osteophyte formation than KLD
(Fig. 3). In all groups, treated defects resulted in a larger percent
volume ﬁlled and lower muscle wastage compared to untreated
defects (Fig. 3). There was no inﬂammatory response among any
conditions.
Conclusions: Premixing KLD with IGF-1, TGF-β1, and dexam-
ethasone in vitro resulted in more ECM production compared to
TGF-β1 and dexamethasone alone. In a rabbit model, KLD pro-
vided a cartilage-like repair with an improved total histology score
and increased Safranin-O staining compared to the bilateral con-
trol empty defect. GF/BMSC interactions in vivo may differ from in
vitro model conditions and may explain differences in results.
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Purpose: Bone marrow progenitor cells (BMSCs) are a promis-
ing cell source for cartilage tissue engineering. Self-assembling
peptide hydrogels are a relatively new class of biomaterials being
studied for cartilage regeneration. A potential difﬁculty for translat-
ing in vitro techniques using BMSCs to animal studies or clinical
applications is that growth factors, such as TGF-β1 (TGF), are
necessary to drive BMSC chondrogenesis. However, repeated
growth factor delivery in vivo is time and cost prohibitive, and
excess growth factor can cause systemic complications. Thus,
the objective of these studies was to evaluate the potential of
self-assembling peptide hydrogels to retain TGF and stimulate
chondrogenic differentiation of BMSCs in vitro.
Methods: Uptake Ratio 125I labeled TGF was adsorbed to KLD
peptide by mixing prior to assembly or adding it to the bath
after assembly. Acellular gels were cultured for 7 days to reach
equilibrium and the ratio of 125I-TGF concentration in the gel to that
in the bath was evaluated. Cell Culture BMSCs were isolated from
2-5 year old horses and expanded in 10% FBS and 5ng/mL bFGF.
BMSCs were encapsulated in KLD peptide hydrogels at 10×106
cells/mL and cultured in basal medium (hg-DMEM, 1% ITS+, 37.5
μg/mL A2P, & 100nM dexamethasone) with or without 10ng/mL
TGF. For the “TGF-takeaway” study, groups of gels cultured in TGF
medium were switched to basal medium after 4, 7, or 14 days.
All gels were cultured for 21 days total. In the “TGF-adsorbed”
study, 100ng/mL TGF was adsorbed to soluble KLD peptide prior
to cell encapsulation. These gels (KLD-Ad) were then cultured
in basal medium alongside KLD gels in either basal (Basal) or
TGF supplemented (TGF) medium for up to 21 days. Data were
analyzed with ANOVA and Tukey’s test for post-hoc comparisons
with signiﬁcance at p<0.05.
Results: The uptake ratio ([TGF] in gel: [TGF] in medium) was
greater than 1 in both cases; however when TGF was adsorbed
onto KLD peptide prior to assembly the uptake ratio was signif-
icantly higher than when TGF was added to the medium post
assembly (Fig. 1). Only 4 days of TGF in the medium was suf-
ﬁcient to stimulate BMSC chondrogenesis; furthermore gels with
TGF in the medium for 14 days showed no differences from gels
with TGF in the medium for the entire culture period (Fig. 2A & B).
Interestingly, when TGF was adsorbed to the KLD peptide prior
Figure 1. 125I-TGF uptake ratio.
